- Home
- AIRI vs TRIB Comparison
AIRI vs TRIB Comparison
Compare AIRI & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- TRIB
- Stock Information
- Founded
- AIRI 1979
- TRIB 1992
- Country
- AIRI United States
- TRIB Ireland
- Employees
- AIRI N/A
- TRIB N/A
- Industry
- AIRI Military/Government/Technical
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AIRI Industrials
- TRIB Health Care
- Exchange
- AIRI Nasdaq
- TRIB Nasdaq
- Market Cap
- AIRI 13.4M
- TRIB 13.0M
- IPO Year
- AIRI N/A
- TRIB N/A
- Fundamental
- Price
- AIRI $3.29
- TRIB $0.78
- Analyst Decision
- AIRI
- TRIB
- Analyst Count
- AIRI 0
- TRIB 0
- Target Price
- AIRI N/A
- TRIB N/A
- AVG Volume (30 Days)
- AIRI 45.6K
- TRIB 2.4M
- Earning Date
- AIRI 08-13-2025
- TRIB 08-13-2025
- Dividend Yield
- AIRI N/A
- TRIB N/A
- EPS Growth
- AIRI N/A
- TRIB N/A
- EPS
- AIRI N/A
- TRIB N/A
- Revenue
- AIRI $53,182,000.00
- TRIB $61,555,000.00
- Revenue This Year
- AIRI $5.59
- TRIB $13.51
- Revenue Next Year
- AIRI $5.00
- TRIB $13.14
- P/E Ratio
- AIRI N/A
- TRIB N/A
- Revenue Growth
- AIRI 0.29
- TRIB 8.31
- 52 Week Low
- AIRI $3.00
- TRIB $0.48
- 52 Week High
- AIRI $9.44
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- AIRI 41.01
- TRIB 56.63
- Support Level
- AIRI $3.33
- TRIB $0.70
- Resistance Level
- AIRI $3.39
- TRIB $0.77
- Average True Range (ATR)
- AIRI 0.14
- TRIB 0.08
- MACD
- AIRI -0.01
- TRIB 0.01
- Stochastic Oscillator
- AIRI 6.25
- TRIB 60.45
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.